Similarly, RAD521–209 expression rescued the viability in BRCA2−/− CAPAN-1 pancreatic cancer cells, which was reduced approximately 4-fold by treatment with RAD52 shRNA. This evidence concerns the gene RAD52 and pancreatic neoplasm.